Evidence map›Paper›PMID 8533758›Full record

ArticleAmerican journal of human genetics1995

Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia.

T M Narcisi, C C Shoulders, S A Chester, J Read, D J Brett, G B Harrison, T T Grantham, M F Fox, S Povey, T W de Bruin

Abstract read
In one paragraph

Article in American journal of human genetics, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 147 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Current Diagnosis and Management of Abetalipoproteinemia.Journal of atherosclerosis and thrombosis · 2021
    Review
  5. Article
  6. Article
  7. The crystal structure of human microsomal triglyceride transfer protein.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  8. Review
  9. Article
  10. Central effects of humanin on hepatic triglyceride secretion.American journal of physiology. Endocrinology and metabolism · 2015
    Article
  11. Clinical utility gene card for: Abetalipoproteinaemia--Update 2014.European journal of human genetics : EJHG · 2015
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Clinical utility gene card for: Abetalipoproteinaemia.European journal of human genetics : EJHG · 2012
    Article
  17. Article
  18. Article
  19. Congenital diarrheal disorders: an updated diagnostic approach.International journal of molecular sciences · 2012
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

T M NarcisiMRC Molecular Medicine Group, Royal Postgraduate Medical School, Hammersmith Hospital, London, United Kingdom.
C C Shoulders
S A Chester
J Read
D J Brett
G B Harrison
T T Grantham
M F Fox
S Povey
T W de Bruin
Hammersmith Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Elevated plasma levels of apolipoprotein B (apoB)-containing lipoproteins constitute a major risk factor for the development of coronary heart disease. In the rare recessively inherited disorder abetalipoproteinemia (ABL) the production of apoB-containing lipoproteins is abolished, despite no abnormality of the apoB gene. In the current study we have characterized the gene encoding a microsomal triglyceride-transfer protein (MTP), localized to chromosome 4q22-24, and have identified a mutation of the MTP gene in both alleles of all individuals in a cohort of eight patients with classical ABL. Each mutant allele is predicted to encode a truncated form of MTP with a variable number of aberrant amino acids at its C-terminal end. Expression of genetically engineered forms of MTP in Cos-1 cells indicates that the C-terminal portion of MTP is necessary for triglyceride-transfer activity. Deletion of 20 amino acids from the carboxyl terminus of the 894-amino-acid protein and a missense mutation of cysteine 878 to serine both abolished activity. These results establish that defects of the MTP gene are the predominant, if not sole, cause of hereditary ABL and that an intact carboxyl terminus is necessary for activity.

Indexed as

GlycoproteinsMutationAbetalipoproteinemiaAdultBase SequenceCarrier ProteinsCholesterol Ester Transfer ProteinsChromosome MappingFemaleHumansInfantMaleMicrosomesMolecular Sequence DataPolymerase Chain ReactionPolymorphism, GeneticCarrier ProteinsCETP protein, humanCholesterol Ester Transfer ProteinsGlycoproteins

Identifiers

PMID8533758
PMCPMC1801399
OpenAlexW1516430698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.